Shrewsbury Stephen B Insider Trades

Insider Trading History

Track insider trading activity for Shrewsbury Stephen B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $3.92k 97,990 shares
Last Trade
Mar 29, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$180k 24,606 shares
$7.30
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $1.2k 30,000 shares
Last Trade
Jan 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$296k 30,000 shares
$9.85
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Sep 21, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$198k 14,780 shares
$13.43
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $591 14,780 shares
Last Trade
Sep 21, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$198k 14,780 shares
$13.43
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $21.6 541 shares
Last Trade
Sep 21, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62.4k 4,650 shares
$13.43
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $777 19,430 shares
Last Trade
Sep 21, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62.4k 4,650 shares
$13.43
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $1.18k 29,587 shares
Last Trade
Sep 21, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$725k 53,954 shares
$13.43
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $2.94k 73,384 shares
Last Trade
Sep 21, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$725k 53,954 shares
$13.43
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $2k 50,000 shares
Last Trade
Jul 20, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$608k 50,000 shares
$12.16
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Apr 22, 2021 Sale
No data
No data
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Apr 22, 2021 Sale
No data
No data
$0.04
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Apr 22, 2021 Sale
No data
No data
$0.04
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Cmo; Senior VP Clinical Dev.
Holding Value $122k 35,000 shares
Last Trade
Mar 10, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Cmo; Senior VP Clinical Dev.
Holding Value $87.3k 25,000 shares
Last Trade
Mar 12, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Cmo; Senior VP Clinical Dev.
Holding Value $109k 31,250 shares
Last Trade
May 08, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.49
Neoleukin Therapeutics
Neoleukin Therapeutics NLTX
Cmo; Senior VP Clinical Dev.
Holding Value $0 0 shares
Last Trade
Mar 06, 2014 Sale
No data
No data
$3.49
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp/regulatory Affairs
Holding Value $417k 25,000 shares
Last Trade
Aug 23, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.8k 25,000 shares
$2.03
$16.66
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp/regulatory Affairs
Holding Value $1M 60,000 shares
Last Trade
Feb 09, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87k 60,000 shares
$1.45
$16.66
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp/regulatory Affairs
Holding Value $2M 120,000 shares
Last Trade
Feb 09, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$174k 120,000 shares
$1.45
$16.66
Sarepta Therapeutics
Sarepta Therapeutics SRPT
Svp/regulatory Affairs
Holding Value $1M 60,000 shares
Last Trade
Jan 26, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81.6k 60,000 shares
$1.36
$16.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up